No description available.

No description available.

Rumination is a well-established risk factor for the onset and maintenance of depression and anxiety and has been identified as a transdiagnostic factor due to its association with multiple forms of psychopathology. A renaissance of psychedelic research shows promise in treating psychopathology with potential for acting on ruminative processes. Despite the growing interest and developments in legality, very few research studies have investigated the psychological consequences of participating in an ayahuasca ceremony in North America. The current study included 30 participants (Mage = 41.03, SD = 7.35; range = 30-59 years; 50.0% women; 76.7% White/Caucasian) who participated in an ayahuasca ceremony at a North American ayahuasca church. Participants were asked to complete seven daily surveys prior to their ceremony (Phase I) and seven daily surveys following their ceremony (Phase II). Multi-level models tested changes in rumination and depression, anxiety, and stress scores across both phases of the study. Significant and large reduction were evidenced in levels of rumination and depression, anxiety, and stress immediately following the ayahuasca ceremony. This effect was maintained during Phase II, with scores remaining lower than Phase I and relatively stable. Furthermore, path models did not support the mediating role of rumination in the negative link between ayahuasca ceremony effects (as indexed via ego-dissolution) and depression, anxiety, and stress scores (though evidence for mediation was found without bootstrapping samples). Findings of this study contribute to the emerging literature on the role that ceremonial ayahuasca use may have on reducing psychological distress.

Depression and anxiety are common psychiatric disturbances in Parkinson's disease (PD). Past studies have demonstrated a relationship between depression and cognitive decline in PD; however, the unique influence of anxiety has not been well studied. The objective of the present study was to differentiate the unique influences of depression and anxiety on cognitive functioning in PD. Sixty-eight cognitively intact PD patients with mild to moderate motor disease severity completed self-report questionnaires and neuropsychological tests. Two hierarchical regression analyses were conducted with executive functioning performance as the criterion variable, and two additional hierarchical regression analyses were conducted with memory performance as the criterion variable. Depression and anxiety, as measured by the Depression Anxiety and Stress Scales (DASS), served as predictors for all analyses. Each set of analyses examined the amount of added, unique variance accounted for by anxiety when depression was entered as the first predictor, and also examined the amount of added, unique variance accounted for by depression when anxiety was entered as the first predictor. It was found that depression significantly predicted delayed recall memory performance when entered as the first and second predictor. In contrast, anxiety did not significantly predict performance on any of the cognitive measures. Two DASS subscales assess for the physical symptoms of anxiety, and these subscales were not significantly correlated with any cognitive variables. However, the DASS subscales tapping into non-physical aspects of anxiety were significantly associated with several cognitive variables. Patients may have endorsed physical symptoms of anxiety due to the symptoms associated with PD, and not as a result of the genuine presence of anxiety. This could have masked a potential relationship between anxiety and cognitive functioning in PD, and suggests that specific components of anxiety may be associated with cognition in PD. Future adaptation of the DASS may be necessary to differentiate the unique influences of depression and anxiety in PD patients.

No description available.